問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
林昆儒
下載
2022-08-01 - 2025-07-31
Condition/Disease
Test Drug
Participate Sites1Sites
Recruiting1Sites
2020-08-01 - 2022-07-31
Obstructive Sleep Apnea of Adult, Mild Cognitive Impairment
18F-AV-45 (AV-45/Amyvid): (E)-4-(2-(6-(2-(2-(2-[18F] fluoroethoxyl) ethoxy)ethoxy)pyridine-3-yl)vinyl)-N-methylbenzenamine，10
Participate Sites4Sites
Recruiting4Sites
2021-08-01 - 2024-07-31
2017-08-01 - 2025-07-31
2019-01-01 - 2020-12-31
Alzheimer's disease
18F-PMPBB3
Participate Sites2Sites
Recruiting2Sites
2019-08-01 - 2021-07-31
investigate the deposition patterns of tau protein with 18F-PM-PBB3 and amyloid protein with 18F-flobetapir in patients with amnestic mild cognitive impairment due to AD
18F-AV-45 for Injection, and 18F-PM-PBB3 for Injection
2019-08-01 - 2022-07-31
*PRESENILE DEMENTIA;SENILE DEMENTIA, UNCOMPLICATED;DEMENTIA IN CONDITIONS CLASSIFIED ELSEWHERE;AMNESTIC SYNDROME
(1)[F18] AV-45 (2) [F-18] PM-PBB3
Participate Sites3Sites
Recruiting3Sites
2018-09-21 - 2028-11-30
2019-08-01 - 2024-07-31
全部
